Skip to main content
SpringerLink
Log in

Tau Protein in Drug-Resistant Epilepsy and Cognitive Decline

  • Chapter
  • First Online:
Inflammation and Epilepsy: New Vistas

Part of the book series: Progress in Inflammation Research ((PIR,volume 88))

  • 491 Accesses

Abstract

Cognitive impairment is common in individuals with epilepsy and can be progressive for some. The multifactorial causes of cognitive impairment depend on the underlying aetiology as well as the severity of epilepsy. Abnormal neuronal activity is observed in both epilepsy and Alzheimer’s disease; epilepsy may increase the risk of neurodegeneration and vice versa. Neuropathology of surgically resected tissues from patients with drug-resistant epilepsy reports age-accelerated pTau accumulation and variable levels of β-amyloid that have been compared with known tauopathies, including chronic traumatic encephalopathy. Epilepsy-specific patterns of pTau may reflect specific cellular drivers and pathways, including the mammalian target of rapamycin (mTOR), oxidative stress and neuroinflammatory pathways, providing novel therapeutic targets. This chapter addresses the existing evidence for the role of tau protein in epilepsy primarily based on neuropathological studies, its contribution to cognitive decline and future research directions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H. Staging of neurofibrillary pathology in Alzheimer’s disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008;18(4):484–96.

    PubMed  PubMed Central  Google Scholar 

  2. Alosco ML, Stein TD, Tripodis Y, Chua AS, Kowall NW, Huber BR, Goldstein LE, Cantu RC, Katz DI, Palmisano JN, Martin B, Cherry JD, Mahar I, Killiany RJ, McClean MD, Au R, Alvarez V, Stern RA, Mez J, McKee AC. Association of white matter rarefaction, arteriolosclerosis, and tau with dementia in chronic traumatic encephalopathy. JAMA Neurol. 2019;76(11):1298–308.

    PubMed  PubMed Central  Google Scholar 

  3. Alosco ML, Cherry JD, Huber BR, Tripodis Y, Baucom Z, Kowall NW, Saltiel N, Goldstein LE, Katz DI, Dwyer B, Daneshvar DH, Palmisano JN, Martin B, Cantu RC, Stern RA, Alvarez VE, Mez J, Stein TD, McKee AC. Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme. Acta Neuropathol. 2020;140(4):495–512.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Alves M, Kenny A, de Leo G, Beamer EH, Engel T. Tau phosphorylation in a mouse model of temporal lobe epilepsy. Front Aging Neurosci. 2019;11:308.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Arena JD, Smith DH, Lee EB, Gibbons GS, Irwin DJ, Robinson JL, Lee VM, Trojanowski JQ, Stewart W, Johnson VE. Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer’s disease. Brain. 2020;143(5):1572–87.

    PubMed  PubMed Central  Google Scholar 

  6. Asken BM, Bauer RM. Chronic traumatic encephalopathy: the horse is still chasing the cart. J Orthop Sports Phys Ther. 2018;48(9):672–5.

    PubMed  Google Scholar 

  7. Bandopadhyay R, Liu JY, Sisodiya SM, Thom M. A comparative study of the dentate gyrus in hippocampal sclerosis in epilepsy and dementia. Neuropathol Appl Neurobiol. 2014;40(2):177–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Bell WR, An Y, Kageyama Y, English C, Rudow GL, Pletnikova O, Thambisetty M, O’Brien R, Moghekar AR, Albert MS, Rabins PV, Resnick SM, Troncoso JC. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer’s disease. Alzheimers Dement. 2019;15(1):8–16.

    PubMed  Google Scholar 

  9. Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW. Tau, tangles, and Alzheimer’s disease. Biochim Biophys Acta. 2005;1739(2-3):216–23.

    CAS  PubMed  Google Scholar 

  10. Blumcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, Palmini A, Jacques TS, Avanzini G, Barkovich AJ, Battaglia G, Becker A, Cepeda C, Cendes F, Colombo N, Crino P, Cross JH, Delalande O, Dubeau F, Duncan J, Guerrini R, Kahane P, Mathern G, Najm I, Ozkara C, Raybaud C, Represa A, Roper SN, Salamon N, Schulze-Bonhage A, Tassi L, Vezzani A, Spreafico R. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52(1):158–74.

    PubMed  Google Scholar 

  11. Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, Pfafflin M, Elger C, Widman G, Schramm J, Becker A, Braun KP, Leijten F, Baayen JC, Aronica E, Chassoux F, Hamer H, Stefan H, Rossler K, Thom M, Walker MC, Sisodiya SM, Duncan JS, McEvoy AW, Pieper T, Holthausen H, Kudernatsch M, Meencke HJ, Kahane P, Schulze-Bonhage A, Zentner J, Heiland DH, Urbach H, Steinhoff BJ, Bast T, Tassi L, Lo Russo G, Ozkara C, Oz B, Krsek P, Vogelgesang S, Runge U, Lerche H, Weber Y, Honavar M, Pimentel J, Arzimanoglou A, Ulate-Campos A, Noachtar S, Hartl E, Schijns O, Guerrini R, Barba C, Jacques TS, Cross JH, Feucht M, Muhlebner A, Grunwald T, Trinka E, Winkler PA, Gil-Nagel A, Toledano Delgado R, Mayer T, Lutz M, Zountsas B, Garganis K, Rosenow F, Hermsen A, von Oertzen TJ, Diepgen TL, Avanzini G, Consortium E. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377(17):1648–56.

    PubMed  Google Scholar 

  12. Braak H, Del Tredici K. The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain. 2015;138(Pt 10):2814–33.

    PubMed  Google Scholar 

  13. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389–404.

    PubMed  PubMed Central  Google Scholar 

  14. Buda O, Arsene D, Ceausu M, Dermengiu D, Curca GC. Georges Marinesco and the early research in neuropathology. Neurology. 2009;72(1):88–91.

    CAS  PubMed  Google Scholar 

  15. Busche MA, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N, Kamath TV, Carlson GA, Nelken I, Hyman BT. Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo. Nat Neurosci. 2019;22(1):57–64.

    CAS  PubMed  Google Scholar 

  16. Cantu RC, Bernick C. History of chronic traumatic encephalopathy. Semin Neurol. 2020;40(4):353–8.

    PubMed  Google Scholar 

  17. Castellani RJ, Perry G. Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges. J Alzheimers Dis. 2019;67(2):447–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Cendes F, Theodore WH, Brinkmann BH, Sulc V, Cascino GD. Neuroimaging of epilepsy Handb Clin Neurol. 2016;136:985–1014.

    Google Scholar 

  19. Cherry JD, Mez J, Crary JF, Tripodis Y, Alvarez VE, Mahar I, Huber BR, Alosco ML, Nicks R, Abdolmohammadi B, Kiernan PT, Evers L, Svirsky S, Babcock K, Gardner HM, Meng G, Nowinski CJ, Martin BM, Dwyer B, Kowall NW, Cantu RC, Goldstein LE, Katz DI, Stern RA, Farrer LA, McKee AC, Stein TD. Variation in TMEM106B in chronic traumatic encephalopathy. Acta Neuropathol Commun. 2018;6(1):115.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Christensen KR, Beach TG, Serrano GE, Kanaan NM. Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways. Acta Neuropathol Commun. 2019;7(1):29.

    PubMed  PubMed Central  Google Scholar 

  21. Chuckowree JA, Vickers JC. Cytoskeletal and morphological alterations underlying axonal sprouting after localized transection of cortical neuron axons in vitro. J Neurosci. 2003;23(9):3715–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Combs B, Hamel C, Kanaan NM. Pathological conformations involving the amino terminus of tau occur early in Alzheimer’s disease and are differentially detected by monoclonal antibodies. Neurobiol Dis. 2016;94:18–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Corsellis JA, Bruton CJ, Freeman-Browne D. The aftermath of boxing. Psychol Med. 1973;3(3):270–303.

    CAS  PubMed  Google Scholar 

  24. Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, Hyman BT, Jellinger K, Jicha GA, Kovacs GG, Knopman DS, Kofler J, Kukull WA, Mackenzie IR, Masliah E, McKee A, Montine TJ, Murray ME, Neltner JH, Santa-Maria I, Seeley WW, Serrano-Pozo A, Shelanski ML, Stein T, Takao M, Thal DR, Toledo JB, Troncoso JC, Vonsattel JP, White CL 3rd, Wisniewski T, Woltjer RL, Yamada M, Nelson PT. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Curatolo P, Moavero R, van Scheppingen J, Aronica E. mTOR dysregulation and tuberous sclerosis-related epilepsy. Expert Rev Neurother. 2018;18(3):185–201.

    CAS  PubMed  Google Scholar 

  26. Deleo F, Thom M, Concha L, Bernasconi A, Bernhardt BC, Bernasconi N. Histological and MRI markers of white matter damage in focal epilepsy. Epilepsy Res. 2018;140:29–38.

    PubMed  Google Scholar 

  27. DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14(1):32.

    PubMed  PubMed Central  Google Scholar 

  28. Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, Aronson MK, Crystal HA. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol. 1994;88(3):212–21.

    CAS  PubMed  Google Scholar 

  29. Dujardin S, Begard S, Caillierez R, Lachaud C, Carrier S, Lieger S, Gonzalez JA, Deramecourt V, Deglon N, Maurage CA, Frosch MP, Hyman BT, Colin M, Buee L. Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathol Commun. 2018;6(1):132.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Duka V, Lee JH, Credle J, Wills J, Oaks A, Smolinsky C, Shah K, Mash DC, Masliah E, Sidhu A. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer’s diseases. PLoS One. 2013;8(9):e75025.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Elverman KH, Resch ZJ, Quasney EE, Sabsevitz DS, Binder JR, Swanson SJ. Temporal lobe epilepsy is associated with distinct cognitive phenotypes. Epilepsy Behav. 2019;96:61–8.

    PubMed  Google Scholar 

  32. Falcon B, Zivanov J, Zhang W, Murzin AG, Garringer HJ, Vidal R, Crowther RA, Newell KL, Ghetti B, Goedert M, Scheres SHW. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568(7752):420–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Feinstein SC, Wilson L. Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death. Biochim Biophys Acta 2005 Jan 3;1739(2-3):268–79. https://doi.org/10.1016/j.bbadis.2004.07.002

  34. Fesharaki-Zadeh A. Chronic traumatic encephalopathy: a brief overview. Front Neurol. 2019;10:713.

    PubMed  PubMed Central  Google Scholar 

  35. Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, Crowther RA, Ghetti B, Goedert M, Scheres SHW. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature. 2017;547(7662):185–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Fu H, Possenti A, Freer R, Nakano Y, Hernandez Villegas NC, Tang M, Cauhy PVM, Lassus BA, Chen S, Fowler SL, Figueroa HY, Huey ED, Johnson GVW, Vendruscolo M, Duff KE. A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology. Nat Neurosci. 2019;22(1):47–56.

    CAS  PubMed  Google Scholar 

  37. Galovic M, van Dooren VQH, Postma T, Vos SB, Caciagli L, Borzi G, Rosillo JC, Vuong KA, de Tisi J, Nachev P, Duncan JS, Koepp MJ. Progressive cortical thinning in patients with focal epilepsy. JAMA Neurol. 2019;76(10):1230–9.

    PubMed  PubMed Central  Google Scholar 

  38. Galovic M, de Tisi J, McEvoy AW, Miserocchi A, Vos SB, Borzì G, Cueva Rosillo J, Vuong KA, Nachev P, Duncan JS, Koepp MJ. Resective surgery prevents progressive cortical thinning in temporal lobe epilepsy. Brain J Neurol. 2020;143(11):3262–72.

    Google Scholar 

  39. Garcia-Cabrero AM, Guerrero-Lopez R, Giraldez BG, Llorens-Martin M, Avila J, Serratosa JM, Sanchez MP. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia. Neurobiol Dis. 2013;58:200–8.

    CAS  PubMed  Google Scholar 

  40. Geddes JF, Vowles GH, Nicoll JA, Revesz T. Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol. 1999;98(2):171–8.

    CAS  PubMed  Google Scholar 

  41. Gibbons GS, Banks RA, Kim B, Changolkar L, Riddle DM, Leight SN, et al. Detection of Alzheimer Disease (AD)-specific tau pathology in AD and NonAD tauopathies by immunohistochemistry with novel conformation-selective tau antibodies. J Neuropathol Exp Neurol. 2018 Mar 1;77:216–228.

    Google Scholar 

  42. Goedert M, Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 1990;9(13):4225–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Goedert M, Eisenberg DS, Crowther RA. Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci. 2017;40:189–210.

    CAS  PubMed  Google Scholar 

  44. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease. Ann Neurol. 1997;41(1):17–24.

    CAS  PubMed  Google Scholar 

  45. Gouras GK, Relkin NR, Sweeney D, Munoz DG, Mackenzie IR, Gandy S. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol. 1997;41(3):402–4.

    CAS  PubMed  Google Scholar 

  46. Gourmaud S, Shou H, Irwin DJ, Sansalone K, Jacobs LM, Lucas TH, Marsh ED, Davis KA, Jensen FE, Talos DM. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy. Brain. 2020;143(1):191–209.

    PubMed  Google Scholar 

  47. Guerrero-Munoz MJ, Gerson J, Castillo-Carranza DL. Tau oligomers: the toxic player at synapses in Alzheimer’s disease. Front Cell Neurosci. 2015;9:464.

    PubMed  PubMed Central  Google Scholar 

  48. Hefti MM, Farrell K, Kim S, Bowles KR, Fowkes ME, Raj T, Crary JF. High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development. PLoS One. 2018;13(4):e0195771.

    PubMed  PubMed Central  Google Scholar 

  49. Hefti MM, Kim S, Bell AJ, Betters RK, Fiock KL, Iida MA, Smalley ME, Farrell K, Fowkes ME, Crary JF. Tau phosphorylation and aggregation in the developing human brain. J Neuropathol Exp Neurol. 2019;78(10):930–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Helmstaedter C, Witt JA. Epilepsy and cognition – a bidirectional relationship? Seizure. 2017;49:83–9.

    Google Scholar 

  51. Hermann B, Seidenberg M, Lee EJ, Chan F, Rutecki P. Cognitive phenotypes in temporal lobe epilepsy. J Int Neuropsychol Soc. 2007;13(1):12–20.

    PubMed  Google Scholar 

  52. Holth JK, Bomben VC, Reed JG, Inoue T, Younkin L, Younkin SG, Pautler RG, Botas J, Noebels JL. Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J Neurosci. 2013;33(4):1651–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Iyer A, Prabowo A, Anink J, Spliet WG, van Rijen PC, Aronica E. Cell injury and premature neurodegeneration in focal malformations of cortical development. Brain Pathol. 2014;24(1):1–17.

    CAS  PubMed  Google Scholar 

  54. Jefferson-George KS, Wolk DA, Lee EB, McMillan CT. Cognitive decline associated with pathological burden in primary age-related tauopathy. Alzheimers Dement. 2017;13(9):1048–53.

    PubMed  PubMed Central  Google Scholar 

  55. Jha A, Teotonio R, Smith AL, Bomanji J, Dickson J, Diehl B, Duncan JS, Nachev P. Metabolic lesion-deficit mapping of human cognition. Brain. 2020;143(3):877–90.

    PubMed  PubMed Central  Google Scholar 

  56. Jones AL, Britton JW, Blessing MM, Parisi JE, Cascino GD. Chronic traumatic encephalopathy in an epilepsy surgery cohort: clinical and pathologic findings. Neurology. 2018;90(6):e474–8.

    PubMed  Google Scholar 

  57. Kakita A, Kameyama S, Hayashi S, Masuda H, Takahashi H. Pathologic features of dysplasia and accompanying alterations observed in surgical specimens from patients with intractable epilepsy. J Child Neurol. 2005;20(4):341–50.

    PubMed  Google Scholar 

  58. Kanaan NM, Cox K, Alvarez VE, Stein TD, Poncil S, McKee AC. Characterization of early pathological tau conformations and phosphorylation in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2016;75(1):19–34.

    CAS  PubMed  Google Scholar 

  59. Kandratavicius L, Monteiro MR, Hallak JE, Carlotti CG Jr, Assirati JA Jr, Leite JP. Microtubule-associated proteins in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with granular cell layer dispersion. Biomed Res Int. 2013;2013:960126.

    PubMed  PubMed Central  Google Scholar 

  60. Katsumoto A, Takeuchi H, Tanaka F. Tau pathology in chronic traumatic encephalopathy and Alzheimer’s disease: similarities and differences. Front Neurol. 2019;10:980.

    PubMed  PubMed Central  Google Scholar 

  61. Kelley CM, Perez SE, Mufson EJ. Tau pathology in the medial temporal lobe of athletes with chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study. Acta Neuropathol Commun. 2019;7(1):207.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Keret O, Hoang TD, Xia F, Rosen HJ, Yaffe K. Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans. JAMA Neurol. 2020;77:710–5.

    PubMed  Google Scholar 

  63. Kobayashi S, Tanaka T, Soeda Y, Almeida OFX, Takashima A. Local somatodendritic translation and hyperphosphorylation of tau protein triggered by AMPA and NMDA receptor stimulation. EBioMedicine. 2017;20:120–6.

    PubMed  PubMed Central  Google Scholar 

  64. Kobayashi S, Tanaka T, Soeda Y, Takashima A. Enhanced tau protein translation by hyper-excitation. Front Aging Neurosci. 2019;11:322.

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Kondo A, Shahpasand K, Mannix R, Qiu J, Moncaster J, Chen CH, Yao Y, Lin YM, Driver JA, Sun Y, Wei S, Luo ML, Albayram O, Huang P, Rotenberg A, Ryo A, Goldstein LE, Pascual-Leone A, McKee AC, Meehan W, Zhou XZ, Lu KP. Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. Nature. 2015;523(7561):431–6.

    PubMed  PubMed Central  Google Scholar 

  66. Kopach O, Esteras N, Wray S, Rusakov DA, Abramov AY. Maturation and phenotype of pathophysiological neuronal excitability of human cells in tau-related dementia. J Cell Sci. 2020;133

    Google Scholar 

  67. Kovacs GG. Astroglia and tau: new perspectives. Front Aging Neurosci. 2020;12:96.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobagyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kovari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemuller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL 3rd, Wisniewski T, Woulfe JM, Yamada M, Dickson DW. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016;131(1):87–102.

    CAS  PubMed  Google Scholar 

  69. La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O’Neil JP, Pham J, Rojas JC, Rosen HJ, Seeley WW, Tsai RM, Miller BL, Jagust WJ, Rabinovici GD. Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524)

    Google Scholar 

  70. Lace G, Savva GM, Forster G, de Silva R, Brayne C, Matthews FE, Barclay JJ, Dakin L, Ince PG, Wharton SB, Mrc C. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain. 2009;132(Pt 5):1324–34.

    CAS  PubMed  Google Scholar 

  71. Lam AD, Deck G, Goldman A, Eskandar EN, Noebels J, Cole AJ. Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer’s disease. Nat Med. 2017;23(6):678–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Lam AD, Sarkis RA, Pellerin KR, Jing J, Dworetzky BA, Hoch DB, Jacobs CS, Lee JW, Weisholtz DS, Zepeda R, Westover MB, Cole AJ, Cash SS. Association of epileptiform abnormalities and seizures in Alzheimer disease. Neurology. 2020;

    Google Scholar 

  73. Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018;25(1):59–70.

    CAS  PubMed  Google Scholar 

  74. Laurent A, Artiges E, Mellerio C, Boutin-Watine M, Landre E, Semah F, Chassoux F. Metabolic correlates of cognitive impairment in mesial temporal lobe epilepsy. Epilepsy Behav. 2020;105:106948.

    PubMed  Google Scholar 

  75. Levenga J, Krishnamurthy P, Rajamohamedsait H, Wong H, Franke TF, Cain P, Sigurdsson EM, Hoeffer CA. Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments. Acta Neuropathol Commun. 2013;1:34.

    PubMed  PubMed Central  Google Scholar 

  76. Ling H, Morris HR, Neal JW, Lees AJ, Hardy J, Holton JL, Revesz T, Williams DD. Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players. Acta Neuropathol. 2017;133(3):337–52.

    PubMed  PubMed Central  Google Scholar 

  77. Liu X, Ou S, Yin M, Xu T, Wang T, Liu Y, Ding X, Yu X, Yuan J, Huang H, Zhang X, Tan X, Chen L, Chen Y. N-methyl-D-aspartate receptors mediate epilepsy-induced axonal impairment and tau phosphorylation via activating glycogen synthase kinase-3beta and cyclin-dependent kinase 5. Discov Med. 2017;23(127):221–34.

    PubMed  Google Scholar 

  78. Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol. 1994;87(5):504–10.

    CAS  PubMed  Google Scholar 

  79. Martinez-Losa M, Tracy TE, Ma K, Verret L, Clemente-Perez A, Khan AS, Cobos I, Ho K, Gan L, Mucke L, Alvarez-Dolado M, Palop JJ. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer’s disease. Neuron. 2018;98(1):75–89. e75

    CAS  PubMed  PubMed Central  Google Scholar 

  80. McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J. Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol. 2017;134(3):459–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  81. McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, Lee HS, Wojtowicz SM, Hall G, Baugh CM, Riley DO, Kubilus CA, Cormier KA, Jacobs MA, Martin BR, Abraham CR, Ikezu T, Reichard RR, Wolozin BL, Budson AE, Goldstein LE, Kowall NW, Cantu RC. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136(Pt 1):43–64.

    PubMed  Google Scholar 

  82. McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, Tripodis Y, Crary JF, Bieniek KF, Dams-O’Connor K, Alvarez VE, Gordon WA, T. C. Group. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131(1):75–86.

    CAS  PubMed  Google Scholar 

  83. Milikovsky DZ, Ofer J, Senatorov VV Jr, Friedman AR, Prager O, Sheintuch L, Elazari N, Veksler R, Zelig D, Weissberg I, Bar-Klein G, Swissa E, Hanael E, Ben-Arie G, Schefenbauer O, Kamintsky L, Saar-Ashkenazy R, Shelef I, Shamir MH, Goldberg I, Glik A, Benninger F, Kaufer D, Friedman A. Paroxysmal slow cortical activity in Alzheimer’s disease and epilepsy is associated with blood-brain barrier dysfunction. Sci Transl Med. 2019;11(521)

    Google Scholar 

  84. Mo L, Ding X, Tan C, Liu X, Wei X, Wang H, Zhou W, Chen L. Association of cerebrospinal fluid zinc-alpha2-glycoprotein and tau protein with temporal lobe epilepsy and related white matter impairment. Neuroreport. 2019;30(8):586–91.

    CAS  PubMed  Google Scholar 

  85. Mondragon-Rodriguez S, Basurto-Islas G, Santa-Maria I, Mena R, Binder LI, Avila J, Smith MA, Perry G, Garcia-Sierra F. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease. Int J Exp Pathol. 2008;89(2):81–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Mondragon-Rodriguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N, Boehm J. Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J Biol Chem. 2012;287(38):32040–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Mondragon-Rodriguez S, Perry G, Luna-Munoz J, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer’s disease and Down syndrome. Neuropathol Appl Neurobiol. 2014;40(2):121–35.

    CAS  PubMed  Google Scholar 

  88. Monti G, Tondelli M, Giovannini G, Bedin R, Nichelli PF, Trenti T, Meletti S, Chiari A. Cerebrospinal fluid tau proteins in status epilepticus. Epilepsy Behav. 2015;49:150–4.

    PubMed  Google Scholar 

  89. Moszczynski AJ, Yang W, Hammond R, Ang LC, Strong MJ. Threonine(175), a novel pathological phosphorylation site on tau protein linked to multiple tauopathies. Acta Neuropathol Commun. 2017;5(1):6.

    PubMed  PubMed Central  Google Scholar 

  90. Moszczynski AJ, Strong W, Xu K, McKee A, Brown A, Strong MJ. Pathologic Thr(175) tau phosphorylation in CTE and CTE with ALS. Neurology. 2018;90(5):e380–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  91. Nakano H, Kobayashi K, Sugimori K, Shimazaki M, Miyazu K, Hayashi M, Furuta H. Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17(3):122–31.

    CAS  PubMed  Google Scholar 

  92. Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodard JL, Van Eldik LJ, Kryscio RJ. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain. 2011;134(Pt 5):1506–18.

    PubMed  PubMed Central  Google Scholar 

  93. Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White Iii CL, Yu L, Schneider JA. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503–27.

    PubMed  PubMed Central  Google Scholar 

  94. Pallo SP, DiMaio J, Cook A, Nilsson B, Johnson GVW. Mechanisms of tau and Abeta-induced excitotoxicity. Brain Res. 2016;1634:119–31.

    CAS  PubMed  Google Scholar 

  95. Palmio J, Suhonen J, Keranen T, Hulkkonen J, Peltola J, Pirttila T. Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure. Seizure. 2009;18(7):474–7.

    PubMed  Google Scholar 

  96. Patel DC, Tewari BP, Chaunsali L, Sontheimer H. Neuron-glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci. 2019;20(5):282–97.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. Peng C, Trojanowski JQ, Lee VM. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16(4):199–212.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Pollard H, Khrestchatisky M, Moreau J, Ben-Ari Y, Represa A. Correlation between reactive sprouting and microtubule protein expression in epileptic hippocampus. Neuroscience. 1994;61(4):773–87.

    CAS  PubMed  Google Scholar 

  99. Pooler AM, Phillips EC, Lau DH, Noble W, Hanger DP. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 2013;14(4):389–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  100. Prabowo AS, Iyer AM, Veersema TJ, Anink JJ, Schouten-van Meeteren AY, Spliet WG, van Rijen PC, Ferrier CH, Thom M, Aronica E. Expression of neurodegenerative disease-related proteins and caspase-3 in glioneuronal tumours. Neuropathol Appl Neurobiol. 2015;41(2):e1–e15.

    CAS  PubMed  Google Scholar 

  101. Prada Jardim A, Liu J, Baber J, Michalak Z, Reeves C, Ellis M, Novy J, de Tisi J, McEvoy A, Miserocchi A, Targas Yacubian EM, Sisodiya S, Thompson P, Thom M. Characterising subtypes of hippocampal sclerosis and reorganization: correlation with pre and postoperative memory deficit. Brain Pathol. 2018;28(2):143–54.

    CAS  PubMed  Google Scholar 

  102. Puvenna V, Engeler M, Banjara M, Brennan C, Schreiber P, Dadas A, Bahrami A, Solanki J, Bandyopadhyay A, Morris JK, Bernick C, Ghosh C, Rapp E, Bazarian JJ, Janigro D. Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy. Brain Res. 2016;1630:225–40.

    CAS  PubMed  Google Scholar 

  103. Ren Y, Sahara N. Characteristics of tau oligomers. Front Neurol. 2013;4:102.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Reyes A, Kaestner E, Bahrami N, Balachandra A, Hegde M, Paul BM, Hermann B, McDonald CR. Cognitive phenotypes in temporal lobe epilepsy are associated with distinct patterns of white matter network abnormalities. Neurology. 2019;92(17):e1957–68.

    PubMed  PubMed Central  Google Scholar 

  105. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer’s disease mouse model. Science. 2007;316(5825):750–4.

    CAS  PubMed  Google Scholar 

  106. Sarnat HB, Flores-Sarnat L. Infantile tauopathies: hemimegalencephaly; tuberous sclerosis complex; focal cortical dysplasia 2; ganglioglioma. Brain and Development. 2015;37(6):553–62.

    PubMed  Google Scholar 

  107. Sarnat H, Flores-Sarnat L, Crino P, Hader W, Bello-Espinosa L. Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis. Folia Neuropathol. 2012;50(4):330–45.

    PubMed  Google Scholar 

  108. Schmidt ML, Zhukareva V, Newell KL, Lee VM, Trojanowski JQ. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer’s disease. Acta Neuropathol. 2001;101(5):518–24.

    CAS  PubMed  Google Scholar 

  109. Sen A, Thom M, Martinian L, Harding B, Cross JH, Nikolic M, Sisodiya SM. Pathological tau tangles localize to focal cortical dysplasia in older patients. Epilepsia. 2007a;48(8):1447–54.

    PubMed  Google Scholar 

  110. Sen A, Thom M, Martinian L, Yogarajah M, Nikolic M, Sisodiya SM. Increased immunoreactivity of cdk5 activators in hippocampal sclerosis. Neuroreport. 2007b;18(5):511–6.

    CAS  PubMed  Google Scholar 

  111. Sen A, Capelli V, Husain M. Cognition and dementia in older patients with epilepsy. Brain. 2018;141(6):1592–608.

    PubMed  PubMed Central  Google Scholar 

  112. Sen A, Jette N, Husain M, Sander JW. Epilepsy in older people. Lancet. 2020;395(10225):735–48.

    PubMed  Google Scholar 

  113. Shafiei SS, Guerrero-Munoz MJ, Castillo-Carranza DL. Tau oligomers: cytotoxicity, propagation, and mitochondrial damage. Front Aging Neurosci. 2017;9:83.

    PubMed  PubMed Central  Google Scholar 

  114. Sheng JG, Boop FA, Mrak RE, Griffin WS. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem. 1994;63(5):1872–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  115. Sima X, Xu J, Li J, Zhong W, You C. Expression of beta-amyloid precursor protein in refractory epilepsy. Mol Med Rep. 2014;9(4):1242–8.

    CAS  PubMed  Google Scholar 

  116. Sindou P, Lesort M, Couratier P, Yardin C, Esclaire F, Hugon J. Glutamate increases tau phosphorylation in primary neuronal cultures from fetal rat cerebral cortex. Brain Res. 1994;646(1):124–8.

    CAS  PubMed  Google Scholar 

  117. Smith DH, Johnson VE, Trojanowski JQ, Stewart W. Chronic traumatic encephalopathy – confusion and controversies. Nat Rev Neurol. 2019a;15(3):179–83.

    Google Scholar 

  118. Smith KM, Blessing MM, Parisi JE, Britton JW, Mandrekar J, Cascino GD. Tau deposition in young adults with drug-resistant focal epilepsy. Epilepsia. 2019b;60(12):2398–403.

    CAS  PubMed  PubMed Central  Google Scholar 

  119. Sotiropoulos I, Galas MC, Silva JM, Skoulakis E, Wegmann S, Maina MB, Blum D, Sayas CL, Mandelkow EM, Mandelkow E, Spillantini MG, Sousa N, Avila J, Medina M, Mudher A, Buee L. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathol Commun. 2017;5(1):91.

    PubMed  PubMed Central  Google Scholar 

  120. Subota A, Pham T, Jette N, Sauro K, Lorenzetti D, Holroyd-Leduc J. The association between dementia and epilepsy: a systematic review and meta-analysis. Epilepsia. 2017;58(6):962–72.

    PubMed  Google Scholar 

  121. Tai XY, Koepp M, Duncan JS, Fox N, Thompson P, Baxendale S, Liu JY, Reeves C, Michalak Z, Thom M. Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections. Brain. 2016;139(Pt 9):2441–55.

    PubMed  PubMed Central  Google Scholar 

  122. Tai XY, Bernhardt B, Thom M, Thompson P, Baxendale S, Koepp M, Bernasconi N. Review: neurodegenerative processes in temporal lobe epilepsy with hippocampal sclerosis: clinical, pathological and neuroimaging evidence. Neuropathol Appl Neurobiol. 2018;44(1):70–90.

    CAS  PubMed  Google Scholar 

  123. Thom M. Review: Hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol. 2014;40(5):520–43.

    PubMed  PubMed Central  Google Scholar 

  124. Thom M, Liu JY, Thompson P, Phadke R, Narkiewicz M, Martinian L, Marsdon D, Koepp M, Caboclo L, Catarino CB, Sisodiya SM. Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study. Brain. 2011;134(Pt 10):2969–81.

    PubMed  PubMed Central  Google Scholar 

  125. Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, Darwish SM, Van Berlo V, Barnes DE, Mantle M, Karydas AM, Coppola G, Roberson ED, Miller BL, Garcia PA, Kirsch HE, Mucke L, Nagarajan SS. Incidence and impact of subclinical epileptiform activity in Alzheimer’s disease. Ann Neurol. 2016;80(6):858–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  126. Whelan CD, Altmann A, Botia JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, Franca W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodriguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargallo N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blumcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kalviainen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O’Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain. 2018;141(2):391–408.

    PubMed  PubMed Central  Google Scholar 

  127. Wu JW, Hussaini SA, Bastille IM, Rodriguez GA, Mrejeru A, Rilett K, Sanders DW, Cook C, Fu H, Boonen RA, Herman M, Nahmani E, Emrani S, Figueroa YH, Diamond MI, Clelland CL, Wray S, Duff KE. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat Neurosci. 2016;19(8):1085–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  128. Xi ZQ, Xiao F, Yuan J, Wang XF, Wang L, Quan FY, Liu GW. Gene expression analysis on anterior temporal neocortex of patients with intractable epilepsy. Synapse. 2009;63(11):1017–28.

    CAS  PubMed  Google Scholar 

  129. Xi ZQ, Wang XF, Shu XF, Chen GJ, Xiao F, Sun JJ, Zhu X. Is intractable epilepsy a tauopathy? Med Hypotheses. 2011;76(6):897–900.

    PubMed  Google Scholar 

  130. Zanier ER, Bertani I, Sammali E, Pischiutta F, Chiaravalloti MA, Vegliante G, Masone A, Corbelli A, Smith DH, Menon DK, Stocchetti N, Fiordaliso F, De Simoni MG, Stewart W, Chiesa R. Induction of a transmissible tau pathology by traumatic brain injury. Brain. 2018;141(9):2685–99.

    PubMed  PubMed Central  Google Scholar 

  131. Zhang L, Guo Y, Hu H, Wang J, Liu Z, Gao F. FDG-PET and NeuN-GFAP immunohistochemistry of hippocampus at different phases of the pilocarpine model of temporal lobe epilepsy. Int J Med Sci. 2015;12:288–294.

    Google Scholar 

  132. Zhang X, Sun B, Wang X, Lu H, Shao F, Rozemuller AJM, Liang H, Liu C, Chen J, Huang M, Zhu K. Phosphorylated TDP-43 staging of primary age-related tauopathy. Neurosci Bull. 2019;35(2):183–92.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK

    Maria Thom & Matthias Koepp

Authors
  1. Maria Thom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias Koepp
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Thom .

Editor information

Editors and Affiliations

  1. Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA

    Damir Janigro

  2. INSERM, Strasbourg, France

    Astrid Nehlig

  3. Cerebrovascular and Glia Research, Department of Neuroscience, Institute of Functional Genomics (UMR 5203 CNRS – U 1191 INSERM, University of Montpellier), Montpellier, France

    Nicola Marchi

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Thom, M., Koepp, M. (2021). Tau Protein in Drug-Resistant Epilepsy and Cognitive Decline. In: Janigro, D., Nehlig, A., Marchi, N. (eds) Inflammation and Epilepsy: New Vistas. Progress in Inflammation Research, vol 88. Springer, Cham. https://doi.org/10.1007/978-3-030-67403-8_7

Download citation

Publish with us

Policies and ethics

Search

Navigation